Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and donepezil for prevention of doxorubicin-induced cardiotoxicity in breast cancer
TCTR20200116007Phase 4Unknown
- Sponsor
- National Science and Technology Development Agency
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, donepezil in breast cancer, Cardiotoxicity, sponsored by National Science and Technology Development Agency. Status: unknown.
02
Drugs
metformindonepezil
03
Conditions
breast cancerCardiotoxicity
Beyond the preview
Go deeper on TCTR20200116007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200116007.